Filter programs:

18 Programs

  • Oncology Today

    Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer

    Explore program
    • April 2026 1.25 ABIM MOC, ABS MOC, CME 51min
      • W
      Wassim Abida
    • April 2026 0.75 ABIM MOC, ABS MOC, CME 27min
      • W
      Wassim Abida
  • Year in Review

    Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer

    Explore program

    +1 more module

  • Rapid Case Review

    Investigators Provide Perspectives on Actual Cases of Metastatic Bladder Cancer

    Explore program

    +2 more modules

  • Cancer Conference Update

    ESMO Congress 2025 Review — Urothelial Bladder Cancer

    Explore program